Atriva Therapeutics gets €24m from EIB

Atriva Therapeutics has secured a €24m loan to push the development of its COVID-19 programme ATR-002, an antiviral, anti-inflammatory MEK inhibitor.

Read more

Topas raises €22m in Series B financining

Topas Therapeutics GmbH will use the €22m proceeds from a Series B Financing to advance two pipeline candidates.

Read more

Siemens launches COVID-19 antigen lateral flow test

Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.

Read more

Priothera closes €30m Series A financing

Priothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML).

Read more

COVID-19 jab: EU signs contract with JNJ

Johnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union.

Read more

Santhera ends development of idebenone

Swiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline.

Read more

Swiss Sophia Genetics to expand globally

Swiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally.

Read more

EIB and EC launch circular bioeconomy fund

The European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of €250m.

·       

Read more